Delivery Order SPE2DR25D2212-SPE2DR26FB9RR
Award Date 1/16/26
Potential Completion Date 1/20/26
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $49,795.38 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors on January 13, 2026, with an ultimate completion date of January 14, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The pharmaceutical product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. AmerisourceBergen is a subsidiary of parent company Cencora, Inc., a major...
- The Defense Logistics Agency awarded a delivery order valued at $36,094.14 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 MG/ML SureClick auto-injectors. This competitively awarded, firm fixed-price contract was issued on December 2, 2025, with an ultimate completion date of December 3, 2025. The contract carries no set-aside designation, indicating open competition among qualified vendors. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the...
- The Defense Logistics Agency awarded a $14,120.29 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military...
- The Defense Logistics Agency awarded a $16,007.47 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 2, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $1,955.33 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors. This competitive award, issued on December 11, 2025, with an ultimate completion date of December 12, 2025, represents a firm fixed-price transaction with no set-aside designation. The drug will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,254.40 to AmerisourceBergen Drug Corp for the supply of REPATHA 140 mg/ml SureClick auto-injectors. The contract, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a firm fixed price delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters and serves as a...
- The Defense Logistics Agency awarded a $11,808.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 10, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. REPATHA is a prescription medication used to treat high cholesterol, and...
- On January 16, 2026, the Defense Logistics Agency awarded a delivery order valued at $16,426.63 to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, which carries an ultimate completion date of January 20, 2026, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor on this award, with its parent company being Cencora, Inc....
- The Defense Logistics Agency awarded a $22,095.24 delivery order to AmerisourceBergen Drug Corp for REPATHA 140 mg/ml SureClick auto-injectors, with an ultimate completion date of December 5, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary pharmaceutical distribution operations....
- The Defense Logistics Agency awarded a $18,521.79 firm fixed-price delivery order to AmerisourceBergen Drug Corp (Conshohocken, PA) on January 13, 2026, for the supply of REPATHA 140 mg/ml SureClick auto-injectors, with completion scheduled for January 14, 2026. This non-competitive delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements. The award is issued under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite...